Two organizations to consider for assisting Ukrainians
March 17, 2022
As conditions continue to worsen in Ukraine, UT Health San Antonio faculty, staff, students and residents may be wondering which organizations they can trust to provide aid to those in need. Here are two to consider: The United for Ukraine Global Fund, …
The Cancer Letter: Latino cancer health equity, Cancer Moonshot converge in San Antonio
March 14, 2022
Multiple individuals from UT Health San Antonio are quoted and pictured in this article, which details Dr. Jill Biden’s recent visit to the Mays Cancer Center and images from the Advancing the Science of Cancer in Latinos conference. Read more
Yahoo Finance: Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials
March 14, 2022
Dr. Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology, and Dr. Ruben Mesa, MD, FACP, executive director of Mays Cancer Center, are quoted in this story. Read more
Message from the COO: COVID-19 numbers down, campus safety protocols updated
March 14, 2022
The Centers for Disease Control and Prevention (CDC) has lowered its COVID-19 community level risk matrix for Bexar County to “Low.” Based on this information, UT Health San Antonio is adjusting campus safety guidelines to allow for the option to wear masks at any time effective March 14.
Reuben Harris, PhD, to chair Department of Biochemistry and Structural Biology
March 11, 2022
Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 11, 2021) — Cancer and virology researcher Reuben Harris, PhD, has been named chairman of the Department of Biochemistry and Structural Biology at The University of Texas Healt …
Staten Island Live: More Latino men are dying by suicide, even as the national rate declines
March 10, 2022
Dr. Luz Maria Garcini of the Center for Research to Advance Community Health is quoted in this article. Read More
Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials
March 10, 2022
An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in- …
Thoracic surgery team achieves highly coveted ranking for lung, esophageal cancer outcomes
March 10, 2022
The UT Health San Antonio Department of Cardiothoracic Surgery has earned a distinguished three-star rating from the Society of Thoracic Surgeons for its patient care and lung and esophageal cancer resection outcomes. The three-star rating denotes the highest category of quality and places the department among the elite for general thoracic surgery.
Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials
March 10, 2022
Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio together with SignalRx Pharmaceuticals Inc. have secured two National Cancer Institute …
Thoracic surgery team achieves highly coveted ranking for lung, esophageal cancer outcomes
March 10, 2022
Only the most elite programs garner 3-star ratings from the Society of Thoracic Surgeons. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (March 10, 2022) — The UT Health San Antonio Department of Cardiothoracic Surgery has earned …